Geode Capital Management’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.28M Sell
218,927
-6,573
-3% -$68.3K ﹤0.01% 3101
2025
Q1
$2.97M Buy
225,500
+4,243
+2% +$55.9K ﹤0.01% 2890
2024
Q4
$3.96M Buy
221,257
+85,557
+63% +$1.53M ﹤0.01% 2854
2024
Q3
$2.19M Buy
135,700
+2,737
+2% +$44.1K ﹤0.01% 3091
2024
Q2
$3.59M Buy
132,963
+49,665
+60% +$1.34M ﹤0.01% 2900
2024
Q1
$1.65M Buy
83,298
+2,026
+2% +$40.1K ﹤0.01% 3189
2023
Q4
$1.68M Buy
81,272
+1,780
+2% +$36.8K ﹤0.01% 3168
2023
Q3
$2.53M Buy
79,492
+583
+0.7% +$18.5K ﹤0.01% 2988
2023
Q2
$2.65M Buy
78,909
+38,448
+95% +$1.29M ﹤0.01% 3024
2023
Q1
$1.69M Buy
40,461
+1,302
+3% +$54.3K ﹤0.01% 3108
2022
Q4
$1.33M Sell
39,159
-1,255
-3% -$42.5K ﹤0.01% 3228
2022
Q3
$1.99M Buy
40,414
+2,408
+6% +$118K ﹤0.01% 3083
2022
Q2
$1.49M Sell
38,006
-19,846
-34% -$780K ﹤0.01% 3226
2022
Q1
$2.13M Sell
57,852
-544
-0.9% -$20.1K ﹤0.01% 3227
2021
Q4
$5.71M Buy
58,396
+687
+1% +$67.2K ﹤0.01% 2826
2021
Q3
$7.2M Buy
57,709
+3,634
+7% +$454K ﹤0.01% 2700
2021
Q2
$6.78M Buy
54,075
+7,450
+16% +$934K ﹤0.01% 2727
2021
Q1
$6.33M Buy
46,625
+6,852
+17% +$930K ﹤0.01% 2666
2020
Q4
$3.61M Buy
39,773
+2,987
+8% +$271K ﹤0.01% 2771
2020
Q3
$2.74M Buy
36,786
+12,816
+53% +$953K ﹤0.01% 2711
2020
Q2
$2.04M Buy
23,970
+14,447
+152% +$1.23M ﹤0.01% 2824
2020
Q1
$688K Buy
9,523
+160
+2% +$11.6K ﹤0.01% 3159
2019
Q4
$668K Sell
9,363
-24
-0.3% -$1.71K ﹤0.01% 3415
2019
Q3
$492K Sell
9,387
-97
-1% -$5.08K ﹤0.01% 3474
2019
Q2
$509K Sell
9,484
-4,278
-31% -$230K ﹤0.01% 3461
2019
Q1
$978K Buy
13,762
+7,918
+135% +$563K ﹤0.01% 3173
2018
Q4
$466K Buy
5,844
+886
+18% +$70.7K ﹤0.01% 3397
2018
Q3
$2.31M Buy
4,958
+903
+22% +$421K ﹤0.01% 2807
2018
Q2
$1.61M Buy
4,055
+885
+28% +$352K ﹤0.01% 2981
2018
Q1
$968K Buy
3,170
+77
+2% +$23.5K ﹤0.01% 3137
2017
Q4
$910K Buy
3,093
+332
+12% +$97.7K ﹤0.01% 3138
2017
Q3
$1.51M Buy
2,761
+731
+36% +$400K ﹤0.01% 2908
2017
Q2
$1.21M Buy
2,030
+381
+23% +$227K ﹤0.01% 3019
2017
Q1
$708K Buy
1,649
+93
+6% +$39.9K ﹤0.01% 3171
2016
Q4
$800K Buy
1,556
+1,184
+318% +$609K ﹤0.01% 3096
2016
Q3
$159K Buy
+372
New +$159K ﹤0.01% 3671